These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 17848882)
21. Successful booster antibody response up to 54 months after single primary vaccination with virosome-formulated, aluminum-free hepatitis A vaccine. Beck BR; Hatz C; Brönnimann R; Herzog C Clin Infect Dis; 2003 Nov; 37(9):e126-8. PubMed ID: 14557982 [TBL] [Abstract][Full Text] [Related]
22. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine]. Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119 [TBL] [Abstract][Full Text] [Related]
23. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951 [TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C. Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195 [TBL] [Abstract][Full Text] [Related]
25. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy. Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W; J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896 [TBL] [Abstract][Full Text] [Related]
26. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years. Kurugöl Z; Mutlubaş F; Ozacar T Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736 [TBL] [Abstract][Full Text] [Related]
27. Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine. Bovier PA; Bock J; Ebengo TF; Frösner G; Glaus J; Herzog C; Loutan L J Med Virol; 2010 Oct; 82(10):1629-34. PubMed ID: 20827757 [TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial. Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305 [TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children. Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis A booster vaccine in children after infant immunization. Kanra G; Yalcin SS; Kara A; Ozmert E; Yurdakök K Pediatr Infect Dis J; 2002 Aug; 21(8):727-30. PubMed ID: 12192159 [TBL] [Abstract][Full Text] [Related]
31. Hepatitis A vaccination of Argentinean infants: comparison of two vaccination schedules. López EL; Contrini MM; Xifró MC; Cattaneo MA; Zambrano B; Dumas R; Rouyrre N; Weber F Vaccine; 2007 Jan; 25(1):102-8. PubMed ID: 16914234 [TBL] [Abstract][Full Text] [Related]
32. Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls. Pedersen C; Breindahl M; Aggarwal N; Berglund J; Oroszlán G; Silfverdal SA; Szüts P; O'Mahony M; David MP; Dobbelaere K; Dubin G; Descamps D J Adolesc Health; 2012 Jan; 50(1):38-46. PubMed ID: 22188832 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous vaccination against hepatitis A and B: results of an open, randomized study from the occupational health point of view. Rieger MA; Hofmann F; Michaelis M Int J Occup Med Environ Health; 2004; 17(3):379-91. PubMed ID: 15683159 [TBL] [Abstract][Full Text] [Related]
34. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors]. Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060 [TBL] [Abstract][Full Text] [Related]
35. Rate, intensity, and duration of local reactions to a virosome-adjuvanted vs. an aluminium-adsorbed hepatitis A vaccine in UK travellers. Clarke PD; Adams P; Ibáñez R; Herzog C Travel Med Infect Dis; 2006 Dec; 4(6):313-8. PubMed ID: 17098626 [TBL] [Abstract][Full Text] [Related]
36. Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs. Pancharoen C; Mekmullica J; Thisyakorn U; Kasempimolporn S; Wilde H; Herzog C Clin Infect Dis; 2005 Nov; 41(10):1537-40. PubMed ID: 16231271 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial. Mayorga Pérez O; Herzog C; Zellmeyer M; Loáisiga A; Frösner G; Egger M J Infect Dis; 2003 Sep; 188(5):671-7. PubMed ID: 12934183 [TBL] [Abstract][Full Text] [Related]
38. Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age. Blatter MM; Klein NP; Shepard JS; Leonardi M; Shapiro S; Schear M; Mufson MA; Martin JM; Varman M; Grogg S; London A; Cambron P; Douha M; Nicholson O; da Costa C; Innis BL Pediatr Infect Dis J; 2012 Aug; 31(8):e133-40. PubMed ID: 22622699 [TBL] [Abstract][Full Text] [Related]
39. Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children. Guerra FA; Gress J; Werzberger A; Reisinger K; Walter E; Lakkis H; Grosso AD; Welebob C; Kuter BJ; Pediatr Infect Dis J; 2006 Oct; 25(10):912-9. PubMed ID: 17006287 [TBL] [Abstract][Full Text] [Related]
40. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children. Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]